Please assess the completion status of the following clinical trial:

Trial Title: Normoglycemia and Neurological Outcome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* non-traumatic SAH, ICH, or TBI~* Glasgow Coma Scale between 6 and 14~* admitted to an ICU of University of Louisville Hospital~Exclusion Criteria:~* Patients \<18 and \>80 years~* GCS Motor score \<4 or an overall GCS score of 15~* diabetic patients who suffer from dialysis-dependent diabetic nephropathy~* patients with multiple injuries~* patients who would have been classified as ASA 3 status prior to their acute neurological event

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Intensive IV Insulin (Type: EXPERIMENTAL): Patients will receive IV insulin to maintain target glucose levels of 80-110 mg/dl
- Conventional Insulin Treatment (Type: ACTIVE_COMPARATOR): Patents will receive conventional IV insulin treatment with target glucose levels of 150-170 mg/dl

Based on this trial design, predict the completion outcome and termination type (if applicable).